Cargando…
The impact of standard accelerated stability conditions on antibody higher order structure as assessed by mass spectrometry
Protein therapeutic higher order structure (HOS) is a quality attribute that can be assessed to help predict shelf life. To model product shelf-life values, possible sample-dependent pathways of degradation that may affect drug efficacy or safety need to be evaluated. As changes in drug thermal stab...
Autores principales: | Kerr, Richard A., Keire, David A., Ye, Hongping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6601562/ https://www.ncbi.nlm.nih.gov/pubmed/30913973 http://dx.doi.org/10.1080/19420862.2019.1599632 |
Ejemplares similares
-
Higher-order structural interrogation of antibodies using middle-down hydrogen/deuterium exchange mass spectrometry
por: Pan, Jingxi, et al.
Publicado: (2016) -
Higher-order structural characterisation of native proteins and complexes by top-down mass spectrometry
por: Zhou, Mowei, et al.
Publicado: (2020) -
NMR Spectroscopy for Protein Higher Order Structure Similarity Assessment in Formulated Drug Products
por: Wang, Deyun, et al.
Publicado: (2021) -
Higher-Order Structural Organization of the Mitochondrial Proteome Charted by In Situ Cross-Linking Mass Spectrometry
por: Hevler, Johannes F., et al.
Publicado: (2023) -
Production and characterization of (60)Fe standards for accelerator mass spectrometry
por: Schumann, Dorothea, et al.
Publicado: (2019)